Top Story

Fresenius Kabi to acquire Akorn

April 25, 2017

Akorn will be acquired by Fresenius Kabi for $4.3 billion, or $34 per share, according to a press release from the companies.

Approximately $450 million of debt will also be assumed in the transaction, which has been approved by the boards of both companies. Akorn shareholders will still need to approve the deal, which is expected to close by early 2018.

Allergan's TrueTear granted marketing authorization

April 25, 2017
The TrueTear intranasal tear neurostimulator has been granted marketing authorization from the FDA, according to an Allergan press release. The hand-held stimulator is…

FDA grants NDA for intravitreal sirolimus for non-infectious uveitis of posterior segment

April 25, 2017
The FDA has accepted a new drug application for intravitreal sirolimus for the treatment of non-infectious uveitis of the posterior segment, Santen announced in a press…

Ivantis cleared to begin trial of Hydrus in advanced glaucoma

April 25, 2017
The FDA has cleared Ivantis to begin a second investigational device exemption clinical trial for its Hydrus microstent, according to a company press release. The…
In the Journals

Study compares outcomes of pediatric primary and secondary IOL implantation

April 24, 2017
Pediatric patients who underwent secondary IOL implantation for pediatric cataract experienced generally worse best corrected visual acuity and a higher risk for…
More News Headlines »
Original Article

Intraocular Pressure After Implantation of a Phakic Collamer Intraocular Lens With a Central Hole

Journal of Refractive Surgery, April 2017, Volume 33 Issue 4
To investigate the middle-term intraocular pressure (IOP) results after implantation of a posterior chamber collagen…
More »

Eye on an Enigma: New Mechanisms of Action in the Medical Management of Glaucoma

This activity is supported by an educational grant from Bausch + Lomb.

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to…
More »
Meeting News

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
More »